Hanns-Ulrich Marschall
Oncology · 2004–2016
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 48 citations into it
- Surgery — 37 citations into it
- Molecular Biology — 33 citations into it
Whom Hanns-Ulrich Marschall trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Hanns-Ulrich Marschall's perspective
Ordered by how strongly the researchers Hanns-Ulrich Marschall trusts endorse each paper. Same corpus, a different order for every researcher.
- Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. (Proceedings of the National Academy of Sciences of the United States of America)
- Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. (Cell Metabolism)
- Identification of membrane-type receptor for bile acids (M-BAR). (Biochemical and Biophysical Research Communications - BBRC)
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. (Journal of the American Medical Association (JAMA))
- Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. (American Journal of Physiology. Endocrinology and Metabolism)
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease (Gut)
- Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes (Science)
- The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice (Science Translational Medicine)
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers (Hepatology)
- Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. (2013) — 2,147 citations
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. (2016) — 2,467 citations
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. (2016) — 957 citations
- Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. (2013) — 875 citations
- Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease (2006) — 1,134 citations
- Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates (2004) — 816 citations